- Home
- Z vs BNTX Comparison
Z vs BNTX Comparison
Compare Z & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | Z | BNTX |
|---|---|---|
| Founded | 2004 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3B | 24.8B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | Z | BNTX |
|---|---|---|
| Price | $43.68 | $97.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 25 | 11 |
| Target Price | $81.48 | ★ $140.31 |
| AVG Volume (30 Days) | ★ 5.5M | 550.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $17.77 | $2.58 |
| Revenue Next Year | $13.25 | N/A |
| P/E Ratio | $499.78 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $41.91 | $90.12 |
| 52 Week High | $93.88 | $124.00 |
Technical Indicators
Market Signals| Indicator | Z | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 31.18 | 33.39 |
| Support Level | $42.21 | $92.18 |
| Resistance Level | $47.31 | $114.30 |
| Average True Range (ATR) | 2.67 | 2.91 |
| MACD | 0.40 | -0.96 |
| Stochastic Oscillator | 16.59 | 2.24 |
Price Performance
Historical ComparisonAbout Z Zillow Group Inc. Class C Capital Stock
Zillow Group Inc is an Internet-based real estate company that offers its customers an on-demand experience for selling, buying, renting, or financing with transparency and ease The group works with real estate agents, brokers, builders, property managers, and landlords to pair technology with top-notch service. The group has brands such as Zillow, Trulia, StreetEasy, Hotpads, Zillow Rentals, Zillow Premier Agent and others.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.